Charles Brandes

Charles Brandes

Last Update: 02-10-2017

Number of Stocks: 176
Number of New Stocks: 21

Total Value: $6,660 Mil
Q/Q Turnover: 4%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

Charles Brandes Watch

  • Brandes 4th Quarter Investor Letter

    When the 2016 history books are written, there likely will be long entries about the failure of the pollster forecasts that year. As shown by the Brexit vote in the United Kingdom and the U.S. Presidential election result, the consensus among pollsters and pundits was spectacularly wrong.

    How could sophisticated collectors and analysts of polling data get it wrong by such significant margins? Without commenting on the politics, we think that behavioral science can partially explain what happened.

    Behavioral science broadly tries to understand how basic human emotions impact decision making. Concepts such as hindsight, herding, overconfidence and extrapolation are just some of the biases that may adversely affect our choices. Click here for definitions of these behavioral biases.

      


  • Eldorado Gold Reports Preliminary Operating Results for 2016

    Eldorado Gold Corp. (NYSE:EGO) announced its preliminary operational results for 2016 and its guidance for 2017 last Friday.


    For the last quarter of 2016, the Canadian gold miner produced 485,994 ounces of gold at an average cash operating cost of $578 per ounce.

      


  • How to Invest in Gold in 2017 Part 5

    Gold for immdediate delivery witnessed a significant jump today. The precious metal increased by 1.08% on the London Bullion Market, up $12.2 per troy ounce to $1,146.80 per troy ounce from yesterday's closing price of $1,134.60.


      


  • Eldorado Gold Announces Approval of Revised Normal Course Issuer Bid by the TSX

    Eldorado Gold Corp. (NYSE:EGO) (TSX:ELD) announced on Monday that The Toronto Stock Exchange has approved its revised normal course issuer bid (NCIB), which allows the Canadian miner to buy back its own shares “through the facilities of the TSX and also through alternate Canadian trading systems.”


    The NCIB grants Eldorado permission to buy back a maximum volume of 2,081,168 of its ordinary shares, or about 0.30% of the total number of shares outstanding. The company had a total of 716,587,134 issued and outstanding shares as of Nov. 28.

      


  • Goldcorp, Eldorado Gold Announce Management Changes

    Eldorado Gold Corp. (NYSE:EGO) and Goldcorp Inc.(NYSE:GG) announced changes in their top management today.


    George Burns, executive vice president and chief operating officer at Goldcorp, will depart the company to join Eldorado Gold Corp. as president and chief executive officer.

      


  • Holdings Charles Brandes Continues to Increase

    Charles Brandes (Trades, Portfolio) is the chairman of Brandes Investment Partners, the firm he started in 1974. In both the second and third quarters the guru bought shares in the following stocks:


    VOXX International Corp. Class A (VOXX)

      


  • Charles Brandes' Top Performing Stocks

    Charles Brandes (Trades, Portfolio) is the chairman of Brandes Investment Partners. He started the firm in 1974 and manages multiple portfolios, including the U.S. Equity and Global Equity. The following are the top performers of his most recent investments.


    Petroleo Brasileiro SA Petrobras ADR (NYSE:PBR.A), with a market cap of $75.59 billion, has gained 240.9% year to date. The guru's stake represents 0.4% of the company's outstanding shares and 2.38% of his total assets.

      


  • Charles Brandes Trimmed Holdings in 2nd Quarter

    In six of his top 10 quarterly transactions, Charles Brandes (Trades, Portfolio), chairman of Brandes Investment Partners, trimmed positions in the portfolio in the second quarter.


    Three of the companies are based in South America, one is based in London, one is based in Luxembourg, and the sixth is based in Chicago.

      


  • Sanofi Sues Merck Over Patent Infringement

    French pharmaceutical giant Sanofi SA (NYSE:SNY) filed a lawsuit against Merck & Co. (NYSE:MRK) for supposed patent infringements last Friday.


    The company has taken action in an attempt to prevent its American rival from releasing a competing version of its best-selling insulin Lantus. Sanofi claims Merck’s international division, Merck Sharp & Dohme Corp., violated up to 10 patents held by the company. Among them are its Lantus and SoloStar products.

      


  • Arnold Schneider Adds to Approach Resources

    Arnold Schneider (Trades, Portfolio) of Schneider Capital Management added to his position in Approach Resources Inc. (NASDAQ:AREX) on Aug. 31.


    Schneider is president, chief investment officer and principal of Schneider Capital, which he founded in 1996. Schneider believes disciplined value investing produces the best investing success over time. He depends on research geared toward identifying stocks and securities that are undervalued but have potential for positive change.

      


  • Mario Gabelli Buys Stake in Higher One

    Mario Gabelli (Trades, Portfolio) purchased a 69,100-share stake in Higher One Holdings (ONE) at an average price of $3.78 per share during the second quarter. Since the purchase Higher One’s market price has gained an estimated 36% in value.


      


  • ITT Tech Shuts Its Doors Amid Investigation

    ITT Technical Institute, a subsidiary of ITT Educational Services Inc. (ESI), closed its doors Tuesday after the government banned the institution from enrolling new students receiving federal aid in August.


    The closure follows accusations by the Institute’s accreditor of mismanagement of its finances and using questionable recruiting tactics. ITT Educational Services is also under investigation by state and federal authorities. After sanctions were implemented by the government, the institution released a statement indicating the chances of staying open were bleak as the institution was not only restricted from receiving federal aid for tuition but also required to increase cash reserves from $94.4 million to $247.3 million.

      


  • Charles Brandes Continues to Invests in Pain Therapeutics

    Charles Brandes (Trades, Portfolio) is the chairman of Brandes Investment Partners. He started the firm in 1974. In both the first and second quarters the guru bought shares in the following stocks:


    ITT Educational Services Inc. (ESI)

      


  • Brandes Funds Comments on Ericsson

    The All-Cap Investment Committee initiated a position in Sweden-based Ericsson (NASDAQ:ERIC). The company is the global leader in wireless infrastructure, with 40% of the world’s mobile traffic running through its networks.

      


  • Brandes Funds Comments on Fuji Media Holdings

    During the quarter, the Small-Cap Investment Committee initiated a position in Japanese Fuji Media Holdings (TSE:4676).

      


  • Brandes Funds Comments on Nokia

    Nokia (NYSE:NOK) has evolved quite significantly over the past few years, divesting several businesses while integrating and acquiring others in an effort to improve its scale and competitive positioning. Historically known as a mobile phone manufacturer, Nokia sold this business to Microsoft for $7.2 billion in 2013. The company also sold its HERE mapping business to a consortium of German carmakers for € 2.55 billion in 2015.


    Nokia largely retained its mobile technology patents after selling off its phone business. As a result, the company now has a patent/technology licensing business which has generated close to $1 billion/year in high-margin revenue. The company is also working to license non-essential patents.

      


  • Brandes Funds Comments on Embraer

    For Embraer (NYSE:ERJ), which derives the majority of its sales outside Brazil, the real’s appreciation continued to present a headwind. The company has also been experiencing margin compression, mainly due to the mature state of its current product mix ahead of the launch of its second-generation models expected in 2018. We see the challenges facing Embraer as temporary in nature and we continue to believe the company represents an attractive investment opportunity.

      


  • Brandes Global Equity Fund 2nd Quarter Commentary

    Market Overview

      


  • Brandes Funds Comments on Kasikornbank

    Established a year later in 1945, Kasikornbank (BKK:KBANK) is Thailand’s fourth-largest bank. The company provides a broad range of consumer, commercial and corporate banking services, including lending, deposit-taking, credit-card services, international-trade financing, custodian services, asset management, investment banking, life insurance and leasing. Moreover, Kasikornbank is the leader in Thailand’s small-/mid-enterprise lending market, which offers higher margins than retail and corporate lending segments.


    The Thai banking industry is in the midst of a credit cycle where asset quality started deteriorating in 2015 due to the slowing economy. In descending order of credit risk, small-/ mid-enterprise lending has represented the highest level of non-performing loans, followed by retail and corporate lending. However, we believe both Bangkok Bank and Kasikornbank are well positioned in the market and offer a margin of safety at their current prices—even after adjusting for further credit deterioration over the next few years.

      


  • Brandes Funds Comments on Bangkok Bank

    Founded in 1944, Bangkok Bank (BKK:BBL) is the largest commercial bank in Thailand with assets, loans, and deposits all commanding over 15% in market share. Bangkok Bank offers a universal banking platform with a full range of consumer, small-/mid-enterprise and corporate financial products and services. Additionally, the company boasts a strong franchise with nearly 1,200 domestic branches, 39 international branches and over 9,000 ATMs.

      


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)